Entrada Therapeutics Inc. (TRDA)

AI Score

Unlock

8.73

0.02 (0.23%)

At close: Apr 24, 2025, 12:53 PM

Entrada Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Revenue	210.78M	215.23M	239.4M	162.87M	129.01M	87.17M	43.43M	25.26M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	2.73M	3.47M	3.37M	3.17M	2.78M	2.57M	2.27M	2.07M	1.52M	1M	500K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Gross Profit	208.05M	211.76M	236.03M	159.7M	126.24M	84.6M	41.16M	23.19M	-1.52M	-1M	-500K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Income	47.01M	57.78M	93.45M	23.73M	3.94M	-26.54M	-66.49M	-73.78M	-97.25M	-90.13M	-78.56M	-64.89M	-51.13M	-41.32M	-33.93M	-29.54M	-26.67M	-18.01M	-11.04M	-5.52M
Interest Income	19.47M	18.64M	16.92M	16.77M	15.22M	11.88M	8.62M	4.81M	2.63M	1.68M	883K	489K	22K	22K	22K	13K	n/a	n/a	n/a	n/a
Pretax Income	66.48M	76.42M	110.38M	40.51M	12.06M	-21.77M	-64.97M	-76.07M	-94.62M	-88.43M	-77.73M	-64.45M	-51.16M	-41.38M	-33.94M	-29.47M	-26.52M	-17.85M	-10.86M	-5.43M
Net Income	65.63M	54.95M	104.44M	23.48M	-6.68M	-19.34M	-78.34M	-74.79M	-88.83M	-85.06M	-75.95M	-63.48M	-51.15M	-41.38M	-33.94M	-29.47M	-26.52M	-17.85M	-10.86M	-5.43M
Selling & General & Admin	38.47M	37.26M	34.82M	33.75M	32.29M	33.53M	32.98M	32.14M	30.64M	26.84M	23.72M	19.46M	15.2M	11.1M	8.52M	6.59M	5.57M	3.57M	2.29M	1.15M
Research & Development	123.47M	117.62M	108.56M	103.72M	99.15M	87.28M	84.05M	73.99M	66.61M	63.29M	54.84M	45.42M	35.93M	30.22M	25.41M	22.95M	21.1M	14.45M	8.75M	4.37M
Other Expenses	-32.03M	-32.03M	-32.03M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Expenses	161.94M	154.88M	143.37M	137.47M	131.44M	120.81M	117.02M	106.14M	97.25M	90.13M	78.56M	64.89M	51.13M	41.32M	33.93M	29.54M	26.67M	18.01M	11.04M	5.52M
Interest Expense	n/a	n/a	n/a	n/a	4.45M	5.39M	6.19M	6.6M	2.63M	1.68M	883K	480K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	163.77M	157.45M	145.94M	139.14M	132.18M	120.81M	117.02M	106.14M	97.25M	90.13M	78.56M	64.89M	51.13M	41.32M	33.93M	29.54M	26.67M	18.01M	11.04M	5.52M
Income Tax Expense	859K	21.47M	5.93M	17.02M	18.74M	-2.42M	13.38M	-1.28M	-5.79M	-3.38M	-1.78M	-973K	-13K	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Shares Outstanding (Basic)	40.84M	40.63M	34.18M	33.5M	33.37M	33.28M	33.16M	32.37M	31.35M	31.3M	31.28M	31.25M	20.78M	28.31M	20.48M	20.48M	20.48M	20.48M	1.05M	1.05M
Shares Outstanding (Diluted)	43.05M	40.63M	35.51M	34.79M	33.37M	34.78M	33.16M	32.37M	31.35M	31.3M	31.28M	31.25M	20.78M	28.31M	20.48M	20.48M	20.48M	20.48M	1.05M	1.05M
EPS (Basic)	1.99	1.67	3.09	0.70	-0.21	-0.63	-2.45	-2.39	-2.84	-3.02	-2.78	-2.54	-2.29	-1.82	-1.65	-6.35	-11.12	-10.7	-10.36	-5.18
EPS (Diluted)	1.91	1.59	2.96	0.63	-0.26	-0.68	-2.45	-2.39	-2.84	-3.02	-2.78	-2.54	-2.29	-1.82	-1.65	-6.35	-11.12	-10.7	-10.36	-5.18
EBITDA	48.94M	59.45M	95.12M	26.13M	-1.16M	-31.85M	-71.28M	-78.83M	-95.35M	-88.4M	-77.04M	-63.58M	-50.01M	-40.47M	-33.29M	-29.08M	-26.34M	-17.79M	-10.9M	-5.45M
EBIT	55.59M	70.66M	110.38M	36.29M	5.18M	-29.59M	-73.59M	-80.88M	-97.25M	-90.13M	-78.56M	-64.89M	-51.13M	-41.32M	-33.93M	-29.54M	-26.67M	-18.01M	-11.04M	-5.52M
Depreciation & Amortization	2.83M	2.57M	3.37M	3.17M	2.78M	2.57M	2.27M	2.03M	1.88M	1.72M	1.52M	1.31M	1.12M	851K	639K	456K	326K	228K	138K	69K